Evidence map›Paper›PMID 36143383›Full record

ArticleLife (Basel, Switzerland)2022

Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy.

Manuel Rodríguez Junquera, María Salgado, Francisco González-Urbistondo, Alberto Alén, José Julián Rodríguez-Reguero, Iria Silva, Eliecer Coto, Pablo Avanzas, César Morís, Juan Gómez and 1 more

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Phenotypic spectrum of the first BelgianFrontiers in genetics · 2024
    Article
  9. An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Manuel Rodríguez JunqueraServicio de Cardiología, Clínica Universitaria de Navarra, 31008 Pamplona, Spain.
María SalgadoHeart Area, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Francisco González-UrbistondoHeart Area, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Alberto AlénHeart Area, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
José Julián Rodríguez-RegueroHeart Area, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Iria SilvaHeart Area, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Eliecer CotoUnidad de Referencia de Cardiopatías Familiares-HUCA, Área del Corazón y Departamento de Genética Molecular, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Pablo AvanzasHeart Area, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0002-4958-6108
César MorísHeart Area, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Juan GómezUnidad de Referencia de Cardiopatías Familiares-HUCA, Área del Corazón y Departamento de Genética Molecular, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0002-3318-4649
Rebeca LorcaHeart Area, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0002-7803-4011
Hospital Universitario Central de Asturias · ESUniversidad de Oviedo · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESUniversidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertrophic cardiomyopathy (HCM) is a monogenic disease with autosomal dominant inheritance. Genotype−phenotype relationships are complex, with variable penetrance even within the same family. The involvement of other modulating genetic and environmental factors is unknown. We aimed to analyze the HCM in monozygotic twins, carriers of the same founder pathogenic variant MYBPC3 p.G263*. The relationship was verified using the PowerPlex 16 HS System kit. Phenotypic differences and environmental differences (overloading conditions, coexistence and location, lifestyle, sport, and intensity) were analyzed. Three pairs of twins genetically identical for all markers and carriers of MYBPC3 G263* were identified. No environmental differences were identified. One of the 89-year-old twins had symptomatic severe obstructive HCM that required septal ablation, while her twin has remained asymptomatic with mild phenotype >80 years. A 49-year-old twin had a severe phenotype of obstructive HCM and pending myectomy, while his twin had a mild asymptomatic phenotype. In the last pair of twins, one presented a much larger left ventricular hypertrophy than his identical twin. In summary, we present three pairs of HCM twin patients sharing not only the genetic cause of the inherited disease but the entire genetic background. Despite identical genetic information and the absence of other known clinical, environmental, or lifestyle differences, the severity of the HCM phenotype is strikingly different. These unexplained differences should prompt the study of other unknown modulating factors, either epigenetic or environmental.

Indexed as

hypertrophic cardiomyopathy (HCM)identical twinsinherited cardiomyopathies

Identifiers

PMID36143383
PMCPMC9506491
OpenAlexW4293773139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.